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Abstract
Aims: To determine whether alcohol-dependent patients in a hospital setting beneﬁt from
extended brief interventions (EBI) delivered by an Alcohol Specialist Nurse.
Methods: Alcohol-dependent patients recruited via screening at the emergency department (ED)
(n = 267), whether or not admitted to hospital, were randomized to EBI (up to six counselling ses-
sions offered) or control. At 6 months, 84.2% of patients were assessed by a researcher blinded to
the intervention. The primary outcome was a fall in Severity of Alcohol Dependence Questionnaire.
Results: There was no difference between groups in the primary outcome [odds ratio (OR) 1.02;
95% conﬁdence interval (CI): 0.38, 2.75, P = 0.97]. Secondary outcomes including alcohol con-
sumption and readiness to change did not show a signiﬁcant difference between groups.
However, all secondary outcome measures improved, on average, in both arms.
Conclusions: Although EBI can be delivered in an ED or inpatient setting, it was not shown to be
an advantage over screening and usual management (which included advice on alternative ser-
vices), with patients in both groups showing an average improvement.
Trial Registration: ISRCTN78062794
INTRODUCTION
Alcohol dependence, as determined by DSM-IV alcohol abuse and
dependence criteria (APA, 1994), affects ~3% of the English
population, and accounts for signiﬁcant medical and psychiatric
morbidity (Anderson et al., 2012). Only a small percentage of these
individuals ever seek treatment for their alcohol use disorder (AUD),
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and for those who do, it is estimated that only 6% ever get access to
a specialist treatment service (HM Government, 2012). A range of
harms ensue from alcohol consumption, many of which are mana-
ged by general hospitals. In 2011/2012, alcohol-related problems
accounted for 1.1 million hospital admissions in England, an
increase of 12% compared with 2008/2009 (NWPHO, 2011). This
ﬁgure does not include the 12% of emergency department (ED)
attendances that are attributed to alcohol, a ﬁgure that increases to
70% at peak times (Pirmohamed et al., 2000). Screening to identify
alcohol-related harm has been deemed inadequate in English acute
hospitals (Patton et al., 2005; Coulton et al., 2009; Drummond
et al., 2014) and might be a missed opportunity if early identiﬁca-
tion and treatment of AUD and co-morbid conditions can reduce
subsequent harm and disease progression and ultimately reduce the
overall burden of alcohol to society including the health service. It is
deemed sensible and practical to ensure that acute hospitals are uti-
lized as an access point for delivery of interventions and referral for
specialist treatment (Owens, 2010; Moriarty et al., 2012).
The ED has been shown to be an environment in which to iden-
tify non-treatment seeking individuals with AUDs (Ryder et al.,
2010), and is potentially an appropriate setting to deliver brief inter-
ventions (BIs; Emmen et al., 2004). It has become common, but not
universal, to refer to structured BIs delivered on more than two
occasions as extended brief interventions (EBIs). BIs are deﬁned as
structured motivational sessions, delivered by healthcare profes-
sionals on 1–6 occasions, typically one session per week aimed at
helping individuals reduce their alcohol consumption (Bien et al.,
1993). Although BIs are effective for non-dependent drinkers, they
may also have some efﬁcacy for reduction in alcohol consumption
in dependent drinkers (Cobain et al., 2011).
BI as a treatment option in acute hospitals has yet to be sys-
tematically studied in a randomized control trial (RCT) in patients
showing features of alcohol dependence (Touquet and Paton, 2006).
However, an observational study of BIs by Alcohol Specialist
Nurses (ASNs) showed that 30% of alcohol-dependent patients
maintained abstinence for 6 months post-intervention (Owens,
2010). Other studies have shown that structured interventions sig-
niﬁcantly reduce length of stay in hospital and produce a signiﬁcant
reduction in alcohol consumption and dependence at 6 months
(Cobain et al., 2011; Hughes et al., 2013). This is consistent with a
recent retrospective evaluation, which showed that alcohol-
dependent and non-dependent patients realized comparable beneﬁt
from BIs delivered by an ASN in acute care (Ryder et al., 2010). BIs
were effective in alcohol-dependent patients suffering alcohol-related
injury (Smith et al., 1998). BIs have been shown to be a valued by
patients, with as many as 93% of patients accepting an intervention
whilst in the ED (Hungerford et al., 2000).
For EBIs, it seems that the duration and intensity of intervention
does not predict effectiveness (MATCH, 1997; UKATT, 2005; Saitz
et al., 2007). Interventions of low duration and intensity may be as
effective as more intensive interventions, and may be more amenable
for implementation in busy acute hospital settings. Although BIs were
not designed for patients with alcohol dependence, and therefore
have not been evaluated in randomized trials in this group, there
appears to be some evidence that they might have some utility and
effectiveness in hospital settings (Crawford et al., 2004; Cobain et al.,
2011). Given the prevalence of alcohol dependence, the high use of
hospitals by this group of patients, and the fact that this is a missed
opportunity for intervening (Touquet and Paton, 2006), we investi-
gated the effectiveness of EBIs for reducing the severity of alcohol
dependence in an acute care setting using a randomized design.
METHODS
Design
Alcohol-dependent patients in an acute hospital setting (ADPAC)
were an RCT to determine if EBIs delivered in an ED were (a) effect-
ive in reducing alcohol dependence, (b) cost effective and (c) valued
by patients. The trial was approved by the research ethics committee
in Liverpool, England (ref: 09/H1005/61) and compliant with the
Declaration of Helsinki 2008; patients gave written informed con-
sent. Oversight was provided by an independent trial steering group.
At an acute general hospital in the North West of England, con-
secutive patients attending the ED irrespective of index cause of
attendance or subsequent admission were screened using the
Alcohol Use Disorders Identiﬁcation Test (AUDIT) set at a score >15
(Saunders et al., 1993), and possible cases referred to the research
nurse for assessment of eligibility. Eligible patients, following con-
sent, were randomized using sequentially numbered opaque sealed
envelopes prepared according to a computer-generated randomiza-
tion allocation sequence. Research nurses who conducted follow-up
assessments at 3 and 6 months were blinded to treatment allocation.
The trial protocol was published (Owens et al., 2011).
The nurse delivering the interventions was an experienced general
nurse who prior to commencement of the study received dedicated
training in delivery of EBI. She received monthly clinical supervision
throughout the study. This nurse delivered all interventions.
Patients randomized to the control arm were given usual clinical
care, which included advice on alternative treatment options. For
the EBI arm, the ﬁrst of a maximum of six interventions was deliv-
ered followed by an invitation to further interventions at 1–2-week
intervals. Follow-up for both groups was planned for 3 and 6
months.
The primary outcome measure was reduction (binary outcome)
in alcohol dependence indexed by the Severity of Alcohol
Dependence Questionnaire (SADQ) at 6 months (Stockwell et al.,
1979). Secondary outcome measures included: reduction in alcohol
consumption; the actual score change in the SADQ; reduction in
AUDIT score, analysed both dichotomized at a value of 16 and as a
continuous measure; Leeds Dependency Questionnaire (LDQ)
(Raistrick et al., 1994); quantity of alcohol consumption in UK units
per drinking day; Readiness to Change Questionnaire (RTCQ)
(Heather et al., 1993); number of ED attendances, length of stay in
hospital and number of hospital admissions, all measured 6 months
pre- and 6 months post-treatment/control; length of stay for initial
treatment in days; and biochemical markers [gamma-glutamyl trans-
ferase (GGT), alanine aminotransferase (ALT) and mean corpuscu-
lar volume (MCV)] when available. EuroQoL EQ-5D (Rabin and de
Charro, 2001) data were collected to provide utility measurement
for cost-effectiveness analysis. We also undertook a qualitative sub-
study to investigate patients’ experiences and perceptions of both
their clinical journey and their involvement in research; this will be
reported in a separate paper.
Baseline data were collected by the ASN performing the screen-
ing and consent process. The nature of delivery of EBI precluded
blinding of participants and the nurse delivering the interventions.
However, the nurses conducting the follow-up assessments at 3 and
6 months remained blinded to treatment allocation, as did the inves-
tigators and statisticians who performed the data analyses: the
research nurses undertaking the follow-up interview did not have
access to trial report forms, and had a script for the patients that
included the phrase ‘…please do not tell me if you visited the hos-
pital nurse for support….’
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Sample size
Based on a previous study of dependent drinkers receiving interven-
tions from an ASN (Cobain et al., 2011), it was expected that 55%
of such patients would display a fall in SADQ score between base-
line and 3-month follow-up. Another confounder in this area of
research is the phenomenon of natural recovery (NR). The NR rate
expected in the control group over this time period was deemed to
be 25% [the literature ranges from 12% with a treatment popula-
tion up to 35% within a general lifetime population (Stockwell
et al., 1979; Bischof et al., 2003; Weisner et al., 2003)]. In order to
detect a difference between the groups (55% vs. 25%) with 90%
power at the 5% signiﬁcance level, 65 patients were therefore
required in each group. In order to allow for an estimated 50%
drop-out rate (observed in previous studies in similar patients), it
was calculated that 130 patients would need to be recruited per
group.
Statistical analysis
Standard statistical software SAS version 9.3 (SAS Institute, Inc.,
Cary, NC, USA) was used. Baseline characteristics are presented by
treatment group and overall, with continuous variables summarized
in terms of means [standard deviations (SD)] or medians [interquar-
tile range (IQR)] depending on the degree of skewness, and categor-
ical variables presented in terms of numbers (%) per category. The
intention-to-treat principle was followed with a two-sided P-value of
0.05 (5% level) for statistical signiﬁcance testing and 95% CIs for
the estimated relative treatment effect reported throughout. To
assess the appropriateness of the event rates used in our sample-size
calculation, an internal pilot was planned when 160 patients had
been randomized. The two main reasons for performing the internal
pilot were to (a) estimate the overall proportion of patients display-
ing a fall in SADQ score to allow comparison with the estimates
used in the original sample-size calculation and (b) monitor the
study recruitment rate and amount of missing data for all primary
and secondary outcomes.
The primary outcome of fall in SADQ score at 6 months post-
randomization is presented with count and percentage for each
group. The fall in SADQ score (binary outcome) was analysed using
logistic regression, and the corresponding ORs estimated to quantify
the treatment effect of EBI against the control. The reasons for miss-
ing primary outcome data are provided with the results of the sensi-
tivity analyses, which were used to investigate the robustness of the
primary outcome results to missing data.
Continuous secondary outcomes that were normally distributed
were analysed using paired t-test, while continuous secondary out-
comes that were non-normally distributed were summarized in
terms of medians and IQR for each treatment group and compared
using the Mann–Whitney U-test. When a secondary outcome was
binary, logistic regression was used to estimate the OR between EBI
and control. Comparisons between the two groups were made for
all outcomes at both 3 and 6 months.
RESULTS
Participants
From January 2010 to January 2011, 390 patients with a suspected
AUD were referred for assessment of eligibility to participate
(Fig. 1). Following assessment including alcohol history and baseline
demographics, 267 patients consented and were randomly assigned
to either the EBI (n = 134) or control (n = 133). Follow-up was
offered according to randomized group, EBI arm at every 2 weeks
and control at 12 weeks.
A ﬁrst intervention was received as an inpatient by 177 patients,
while the remaining 87 patients received their ﬁrst intervention in
the ED. Setting was not recorded for 3 (1%) of the ﬁrst interven-
tions. All follow-up interventions were delivered in the outpatient
clinic setting.
Three-month follow-up was completed in 234 patients (87.6%)
and in 225 patients (84.2%) at 6 months. All in the EBI arm
received at least 1 EBI, and 98 (73%) attended at least one further
session. The mean number of interventions delivered was 3.0 (range
1–6), with mean duration of 19.6minutes per session (range 18–22).
Internal pilot and baseline imbalance
For patients recruited after the internal pilot, it was noted that there
was an imbalance in the baseline primary outcome measure (SADQ)
(Table 1). Since the probability of this occurring by chance was cal-
culated to be 3 × 10−9, failure of randomization was independently
investigated, and no deﬁnite cause could be determined. Given these
ﬁndings, it was agreed between the trial management group and the
independent trial steering committee that pooling of the pre- and
post-pilot data would be based on the following criterion:
The primary analysis was to be the difference between the two
treatment groups (intervention and control) in the rate of fall in
SADQ at 6 months. This difference (plus 95% CIs) would be calcu-
lated for the pre- and post-pilot data. If the difference in rate of pre-
and post-pilots was >10%, then the pre- and post-pilot results
would not be pooled, but if it was ≤10%, the pre- and post-pilot
results would be pooled in a meta-analysis.
The difference in proportions between the pre- and post-pilot
data was 12% (95% CI, 11%, 14%), and thus no pooling was con-
ducted. Therefore, the results for only the pre-pilot data are shown
(n = 160) (Table 1).
Analysis of the primary outcome
One hundred and sixty patients were randomly allocated to treat-
ment (n = 79) or control (n = 81) arms before the internal pilot
(Table 2). The fall in SADQ at 6 months was similar between the
two groups, with an OR 1.02 (95% CI: 0.38–2.75).
Sensitivity analysis of missing primary outcome
Sensitivity analysis was carried out to investigate the robustness of
the conclusions concerning the analysis of the primary outcome to
assumptions about the missing data. In the cases of 6 alcohol-related
deaths, 4 withdrawn consents and 17 un-contactable patients, no
fall in SADQ was assumed, whereas for two patients entering long-
term rehabilitation, a fall in SADQ was assumed. The estimated OR
for the treatment difference in this sensitivity analysis was 1.03
(95% CI: 0.52–2.05), a negligible change from the primary analysis.
Analysis of secondary outcomes
A statistically signiﬁcant difference between the two groups at 6
months was not observed for any of the secondary outcomes
(Table 2). A reduction in alcohol consumption was observed in both
groups, which continued to decrease between 3 and 6 months. The
difference between the two groups was statistically signiﬁcant at 3
months but not by 6 months. Similarly, the LDQ showed a statistic-
ally signiﬁcant difference between the two groups at 3 months, but
not at 6 months.
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Economic assessment
The number of general practitioner contacts, hospital admissions,
emergency attendances and total length of hospital stay in the 6 months
prior to study entry showed no important differences between the two
groups. In addition, the baseline quality of life scores was not statistic-
ally different. In the 6 months following study entry, the total length of
hospital stays fell for both groups but the fall was larger for the EBI
arm such that the mean difference between the EBI arm (3.46 days) and
the control arm (7.37 days) was statistically signiﬁcant (P = 0.02). For
the other economic outcomes, including EQ-5D measures, there was no
difference between the groups at 6-month post-study entry. Whilst there
is some evidence that there was a reduction in healthcare utilization
from EBIs, with no differences in the primary outcomes or utility, there
was insufﬁcient evidence to state that EBIs are cost effective.
DISCUSSION
Given the UK epidemic of alcohol-related harm, and evidence that
interventions in an acute hospital setting can have a positive impact on
a range of measures from decreased alcohol consumption to reduced
readmission (Patton et al., 2005; Nilsen et al., 2008; Hughes et al.,
2013; Wei et al., 2015), we must consider the possibility that patients
presenting to acute hospitals may beneﬁt from intervention (Moriarty
et al., 2012; Patton and O’Hara, 2013). In contrast to some studies
(Cherpitel, 2007; Drummond et al., 2014) and in concordance with
others (D’Onofrio and Degutis, 2002; Désy and Perhats, 2008;
Cunningham et al., 2010; Désy et al., 2010), our research did not
identify problems using ED as a gateway for identiﬁcation of AUD.
Therefore, we should use alcohol-related presentation as an opportun-
ity to (a) identify non-treatment seeking individuals (Crawford et al.,
2004), (b) remind patients about the harms of alcohol misuse, (c) pro-
vide patients with support during their hospital stay, and most import-
antly, (d) as our control group perhaps beneﬁtted from a single session
with advice only, provide advice on where and how to access support
following hospital discharge.
The only systematic review examining the effects of BIs in ‘heavy
drinkers’ demonstrated clear beneﬁts (McQueen et al., 2011), and
Mdege et al. (2014) found that patients admitted with AUD asso-
ciated with gastroenterology or emergency presentation responded
well; however, Daeppen et al. (2007) failed to demonstrate beneﬁt.
In our trial, the ASN gave advice as needed or requested, irre-
spective of allocation to treatment, which could constitute an inter-
vention in itself. It was interesting that at baseline, although half of
the patients had previous treatment for AUD, almost all showed
awareness of and planning toward addressing their AUD on mea-
sures of RTCQ (Heather et al., 1993). This may suggest that the
act of being assessed by the ASN was important in motivating non-
treatment seeking patients to seek treatment (Cobain et al., 2011).
Although systematic testing of interventions for dependent drin-
kers in hospital settings is scarce, there are promising results from
three studies (Chick et al., 1985; Owens, 2010; Ryder et al., 2010).
However, both the mode of intervention and categorization of
patient groups varied, and none used patient by patient randomiza-
tion. To avoid crossover between AUD of lower severity of depend-
ence seen in previous trials (Guth et al., 2008), we chose SADQ as
Assessed for eligibility
N=390
Excluded (n=123)
AUDIT<16 (n=47)
Not meeting other inclusion criterion (n=69)
Declined to participate (n=7)
Randomization
n=267
Analysed for the primary outcome (n=111)
Lost to follow-up (n=22)
Not contactable (n=10)
Alcohol related Rehabilitation (n=2)
Consent withdrawn (n=4)
Death (n=6)
Analysed for the primary outcome (n=117)
Lost to follow-up (n=17)
Not contactable (n=12)
Alcohol related Rehabilitation (n=0)
Consent withdrawn (n=2)
Death (n=3)
Allocated to EBI (n=134)
Received allocated intervention (n=134)
Allocated to Control (n=133)
Received allocated intervention (n=133)
Enrolment
Analysis
Follow-Up
Allocation
Fig. 1. ADPAC Trial CONSORT Flow diagram.
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Table 1. Baseline characteristics for EBI patients and controls before and after the internal pilot
Pre-internal pilot Post-internal pilot
Control EBI Control EBI
N = 81 N = 79 N = 52 N = 55
Gender, n (%): male 56 (69.1) 51 (64.6) 32 (61.5) 33 (60.0)
Age (years) mean (SD), range 49.9 (11.9),
25.3–75.8
50.8 (11.2),
20.8–83.7
48.2 (16.1),
19.0–87.7
47.1 (14.6),
19.4–74.2
Ethnicity, n (%)
White 80 (98.8) 79 (100.0) 52 (100.0) 55 (100.0)
Black or Black British 1 (1.2) 0 0 0
Employment status, n (%)
Employed 15 (18.8) 12 (15.2) 6 (11.8) 15 (27.3)
Unemployed 65 (80.2) 67 (84.8) 45 (88.2) 40 (73.7)
Missing 1 (1.2) 0 (0) 1 (2.0) 0
Marital status, n (%)
Married/cohabiting 25 (30.0) 26 (32.9) 18 (34.6) 22 (40.0)
Divorced/single/widow/widower 52 (64.1) 51 (64.5) 34 (65.3) 33 (60.0)
Missing 4 (4.9) 2 (2.5) 0 0
Accommodation, n (%)
Owner/rented 31 (38.7)/45 (56.3) 27 (35.5)/46 (60.5) 17 (32.7)/34 (65.4) 20 (37.0)/32 (59.3)
Homeless 4 (5.0) 3 (4.0) 1 (1.9) 2 (3.7)
Missing 1 (1.2) 3 (3.8) 0 1 (1.8)
Live alone, n (%) 49 (63.6) 43 (57.3) 23 (45.1) 17 (31.5)
Drinking measures
Previous treatment of alcohol dependence, n (%) yes 55 (67.9) 51 (64.6) 24 (46.2) 23 (41.8)
Primary care prescribing for acute alcohol withdrawal 9 (9.7) 15 (16.8) 3 (12.5) 5 (21.7)
Counselling 27 (29.0) 20 (22.5) 8 (33.3) 13 (56.5)
Admissions for alcohol dependence 34 (36.6) 32 (36.0) 8 (33.3) 8 (34.8)
Admissions/outpatient support from a tertiary centre 23 (24.7) 22 (24.7) 9 (37.5) 9 (39.1)
SADQ
Mean (SD) 36.1 (13.8) 35.5 (15.2) 20.4 (15.0) 39.6 (13.8)
Range 10.0–57.0 5.0–56.0 3.0–56.0 9.0–60.0
Median (IQR) 39.0 (26.0, 49.0) 40.0 (22.0, 49.0) 13.5 (8.5, 33.5) 43.0 (30.0, 52.0)
AUDIT
Mean (SD) 34.7 (6.8) 33.6 (7.0) 29.1 (7.3) 35.6 (5.4)
Range 16.0–40.0 18.0–40.0 18.0–40.0 20.0–40.0
Median (IQR) 38.0 (31.0, 40.0) 36.0 (29.0, 40.0) 29.5 (22.0, 35.5) 38.0 (31.0, 40.0)
AUDIT-C
Mean (SD) 11.9 (0.5) 11.7 (0.7) 11.6 (0.7) 12.0 (0.2)
Range 9.0–12.0 9.0–12.0 9.0–12.0 11.0–12.0
Median (IQR) 12.0 (12.0, 12.0) 12.0 (12.0, 12.0) 12.0 (11.0, 12.0) 12.0 (12.0, 12.0)
LDQ
Mean (SD) 23.8 (7.7) 25.0 (6.3) 14.0 (9.1) 25.0 (7.3)
Range 0.0–30.0 8.0–30.0 2.0–30.0 7.0–30.0
Median (IQR) 27.0 (17.0, 30.0) 29.0 (20.0, 30.0) 11.0 (6.5, 21.0) 30.0 (20.0, 30.0)
Missing, n (%) 5 (6.2) 2 (2.5) 0 0
RCTQ, n (%)
Action (A) 19 (23.5) 16 (20.3) 22 (42.3) 13 (23.6)
Contemplation (C) 58 (71.6) 61 (77.2) 28 (53.8) 42 (76.4)
Pre-contemplation (PC) 4 (4.9) 2 (2.5) 2 (3.8) 0
Duration of alcohol dependence (years) median (IQR),
range
10.0 (4–16),
0–50
10.0 (4–20),
0–60
10.0 (3.0, 17.0),
0–40
6.0 (2.0, 10.0),
0–50
Number of alcohol-drinking days per week
Mean (SD) 6.7 (0.8) 6.7 (1.0) 6.2 (1.5) 6.7 (0.8)
Range 3.0–7.0 3.0–7.0 3.0–7.0 3.0–7.0
Median (IQR) 7.0 (7.0, 7.0) 7.0 (7.0, 7.0) 7.0 (5.0, 7.0) 7.0 (7.0, 7.0)
Number of units (1 unit = 8 g) of alcohol per day
Mean (SD) 30.4 (14.2) 32.4 (19.1) 21.1 (13.7) 37.2 (16.2)
Range 7.0–80.0 8.0–120.0 8.0–70.0 14.0–80.0
Median (IQR) 30.0 (20.0, 40.0) 30.0 (18.0–40.0) 15.0 (12.5, 30.0) 30.0 (25.0, 50.0)
Alcohol consumption per week
Mean (SD) 204.3 (101.0) 216.4 (129.5) 135.3 (100.1) 252.7 (118.5)
Range 49.0–560.0 42.0–840.0 24.0–490.0 45.0–560.0
Median (IQR) 210.0 (126.0, 280.0) 210.0 (120.0, 280.0) 98.0 (66.5, 210.0) 210.0 (168.0, 350.0)
Continued
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the primary outcome measure to ensure that we had accurately
described and categorized the patients severity of dependence.
Although we were unable to demonstrate an effect on the primary
outcome, we did observe signiﬁcant short-term (3 months) reduction
in LDQ and alcohol consumption in the EBI arm, but this signiﬁcant
difference was lost by 6 months.
Strengths and weaknesses
During the ﬁnal analysis, an imbalance in the primary outcome meas-
ure was identiﬁed for patients recruited after the internal pilot. The
investigators sought advice from the independent trial steering com-
mittee. A full independent investigation identiﬁed no errors, and a
subsequent examination conﬁrmed research protocol compliance.
Since the imbalance could not be explained, but the comparative
results of pre- and post-pilots differed by more than an amount speci-
ﬁed in advance, we have reported ﬁndings in only those patients
randomized prior to the internal pilot. This reduced the total number
of patients in the trial, and our trial is therefore under-powered to
detect the target difference originally speciﬁed. Furthermore, although
the trial was designed to limit bias by blinding research nurses collect-
ing outcome measures at follow-up, we relied on patients not to
reveal their allocation. The strengths of the trial included the high
recruitment conversion rate from screening to eligibility (68.4%) and
follow-up rate (86%), which compares favourably with similar stud-
ies (Patton et al., 2005; Daeppen et al., 2007). Furthermore, as the
ﬁrst intervention was delivered at the time of assessment, all patients
in the intervention group received at least one EBI.
Explaining the ‘negative’ result
Although we failed to establish a signiﬁcant difference between the
treatment and control groups, it is interesting that both groups
improved on all measures between baseline and the 6 months. This
Table 1. Continued
Pre-internal pilot Post-internal pilot
Control EBI Control EBI
N = 81 N = 79 N = 52 N = 55
Current and previous ED/hospital admissions
Number of ED attendances in the past 6 months
Patients with data 76 (93.8%) 75 (94.9%) 50 (96.2%) 54 (98.2%)
Mean (SD) 1.84 (1.67) 1.83 (1.84) 1.42 (0.93) 1.69 (1.46)
Range 0–10 0–14 0–5 0–8
Median (IQR) 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 1.0 (1.0, 1.8) 1.0 (1.0, 2.0)
Length of stay sum days in hospital in the past 6 months
Patients with data 76 (93.8%) 75 (94.9%) 50 (96.2%) 54 (98.2%)
Mean (SD) 9.29 (11.05) 10.33 (12.48) 7.52 (15.01) 7.76 (8.30)
Range 0–64 0–70 0–99 0–32
Median (IQR) 7.0 (3.0, 12.0) 6.0 (2.0, 14.0) 4.0 (2.0, 6.8) 5.0 (2.0, 9.8)
Number of hospital admissions in the past 6 months
Patients with data 76 (93.8%) 75 (94.9%) 50 (96.2%) 54 (98.2%)
Mean (SD) 2.37 (4.28) 2.15 (2.41) 1.76 (1.81) 1.57 (1.52)
Range 0–32 0–16 0–8 0–7
Median (IQR) 1.0 (1.0, 2.0) 1.0 (1.0, 3.0) 1.0 (1.0, 2.0) 1.0 (1.0, 2.0)
Euroqol EQ-5D
Mean (SD) 0.72 (0.29) 0.73 (0.26) 0.62 (0.35) 0.64 (0.31)
Range −0.26 to 1 −0.19 to 1 −0.32 to 1 −0.22 to 1
Median (IQR) 0.81 (0.52, 1) 0.78 (0.59, 1) 0.73 (0.41, 0.85) 0.73 (0.52, 0.85)
Biochemical indicators of co-morbid conditionsa
GGT
Mean (SD) 309.0 (274.9) 284.4 (295.8) 201.0 (242.5) 261.6 (349.3)
Range 14.0–999.0 17.0–999.0 5.0–999.0 12.0–2014.0
Median (IQR) 221.0 (94.0, 456.0) 126.0 (65.0, 535.0) 75.5 (33.0, 298.0) 137.0 (54.0, 301.0)
Missing, n (%) 23 (28.4) 28 (35.4) 14 (26.9) 9 (16.4)
ALT
Mean (SD) 61.6 (60.1) 72.2 (80.9) 49.0 (45.5) 77.7 (97.8)
Range 6.0–348.0 10.0–516.0 9.0–199.0 9.0–483.0
Median (IQR) 38.0 (26.0, 84.0) 46.0 (26.0, 80.0) 35.5 (19.0, 62.0) 42.5 (24.5, 85.5)
Missing, n (%) 22 (27.2) 22 (27.8) 10 (19.2) 3 (5.5)
MCV
Mean (SD) 97.7 (7.5) 95.8 (8.3) 96.0 (7.3) 125.2 (145.2)
Range 82.0–122.0 79.0–113.0 83.0–114.0 83.0–943.0
Median (IQR) 98.0 (92.0, 102.0) 96.0 (92.0,103.0) 96.0 (90.0, 100.0) 99.0 (93.0, 103.0)
Missing, n (%) 38 (46.9) 34 (43.0) 21 (40.4) 21 (38.2)
aBiochemical indicators of co-morbid conditions measures (GGT, ALT and MCV) were available only if a patient was admitted to a hospital with a more ser-
ious status. As a result, the measurements are available only for a sub-group who had a more severe condition, and not for everyone randomized, hence the high
missing %.
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Table 2. Primary and secondary outcome analyses for all alcohol consumption measures
Outcome Control EBI Treatment effect: EBI vs Control
N = 81 N = 79 (95% CI), P-value
Fall in SADQ at 6 months
Yes, n (%) 56 (86.2) 57 (86.4) 1.02 (0.38, 2.75), 0.9722b
No 9 9
Missing, n (%) 16 (20) 13 (16) 29 (18)
Fall in SADQ in 12 weeks
Yes, n (%) 49 (74.2) 59 (84.3) 1.86 (0.80, 4.34), 0.1511b
No 17 11
Missing, n (%) 15 (18) 9 (11) 24 (15)
SADQ continuous score at 12 weeks
Median (IQR) 19.5 (3.0, 43.0) 11.5 (0.0, 32.0) −3.00 (−11.00, 0.00), 0.1807c
Missing, n (%) 15 (18) 9 (11) 24 (15)
SADQ continuous score at 6 months
Median (IQR) 14.0 (3.0, 32.0) 7.0 (0.0, 30.0) −1.00 (−7.00, 1.00), 0.2874c
Missing, n (%) 16 (20) 13 (16) 29 (18)
AUDIT at 12 weeks
<16, n (%) 23 (35.4) 36 (51.4) 1.93 (0.97, 3.86), 0.0617b
≥16 42 34
Missing, n (%) 16 (20) 9 (11) 25 (16)
AUDIT at 6 months
<16, n (%) 25 (39.7) 30 (44.8) 1.23 (0.61, 2.48), 0.5571b
≥16 38 37
Missing, n (%) 18 (22) 12 (15) 30 (19)
AUDIT continuous score at 12 weeks
Median (IQR) 30 (8, 36) 15 (8, 36) −2.00 (−8.00, 2.00), 0.3327c
Missing, n (%) 16 (20) 9 (11) 25 (16)
AUDIT continuous score at 6 months
Median (IQR) 24 (8, 35) 16 (5, 36) −1.00 (−7.00, 2.00), 0.5057c
Missing, n (%) 18 (22) 12 (15) 30 (19)
RTCQ at 12 weeks
A, n (%) 45 (68.2) 52 (74.3) 1.35 (0.64, 2.84), 0.4322d
C, n (%) 21 (31.8) 17 (24.3)
PC, n (%) 0 1 (1.4)
C/PC, n (%) 21 (31.8) 18 (25.7)
Missing, n (%) 15 (19) 9 (11) 24 (15)
RTCQ at 6 months
A, n (%) 45 (71.4) 49 (74.2) 1.15 (0.53, 2.51), 0.7195d
C, n (%) 18 (28.6) 16 (24.2)
PC, n (%) 0 1 (1.5)
C/PC, n (%) 18 (28.6) 17 (25.8)
Missing, n (%) 18 (22) 13 (16) 31 (19)
LDQ at 12 weeks
Median (IQR) 14 (0, 26) 2 (0, 18) −1.00 (−8.00, 0.00), 0.0384c
Missing, n (%) 16 (20) 9 (11) 25 (16)
LDQ at 6 months
Median (IQR) 9 (0, 19) 1.5 (0, 18) 0.00 (−4.00, 0.00), 0.2262c
Missing, n (%) 18 (22) 13 (16) 25 (16)
Alcohol consumption at 12 weeksa
Median (IQR) 126 (4, 210) 42 (0, 126) −28.00 (−84.00, 0.00), 0.0267c
Missing, n(%) 17 (21) 9 (11) 26 (16)
Alcohol consumption at 6 monthsa
Median (IQR) 84 (9, 154) 36 (0, 126) −14.00 (−48.00, 0.00), 0.1098c
Missing, n (%) 18 (22) 16 (20) 34 (21)
Note: Biochemical indicators of co-morbid conditions measures (GGT, ALT and MCV) were not routinely done during follow-up. These were available only if
a patient was admitted to a hospital with a more serious status. As a result, follow-up measurements are available only for a sub-group who had a more severe
condition, and not for everyone randomized. The average number of missing was about 70% at 12 weeks and 6 months, and therefore, comparison between the
two treatment groups was not performed.
aAlcohol consumption was calculated as number of units per drinking day × number of drinking days per week.
bLogistic regression (OR).
cWilcoxon Two-Sample Test (mean difference).
dLogistic regression for binary (A, C/PC) RTCQ.
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ﬁnding has been seen in other alcohol treatment research studies,
which often fail to ﬁnd differences either between different treatment
groups (UKATT, 2005) or treatments compared with controls (Saitz
et al., 2007). A systematic review and meta-analysis of studies in
this population and similar to this trial design explained this failure
by concluding that exposure of controls to assessments introduces
bias, which results in the effectiveness of BIs being underestimated
(McCambridge and Kypri, 2011; McCambridge et al., 2011).
Described as ‘assessment reactivity’ (Clifford et al., 2007; Maisto
et al., 2007; Bernstein et al., 2010) or Hawthorne-like effects (Feil
et al., 2002), it is likely that interest and care shown to patients dur-
ing the initial assessment had a positive impact (Nilsen et al., 2008).
An additional consideration for changes in controls could be the
phenomenon of ‘natural recovery’ (Sobell et al., 2000; Bischof et al.,
2003) where between 12% and 35% of alcohol-dependent indivi-
duals ‘recover’ with little or no specialist intervention. A meta-
analysis of BIs across a variety of settings (Jenkins et al., 2009)
demonstrated heterogeneity amongst studies, but nevertheless
showed a reduction in alcohol consumption in control groups, espe-
cially in trials conducted in Anglophone countries. Furthermore, in
16 studies where controls received some form of alcohol advice,
there was a reduction in consumption (Bernstein et al., 2010). It is
possible that this has also been the case in our trial, particularly,
since the control group received three assessments; at baseline, 3 and
6 months, which may have a potential cumulative effect.
Finally, regression to the mean has been postulated to be an arte-
fact of the heterogeneity and extremes observed within this rather
complex and unhealthy patient group, who are detected by deﬁn-
ition when they have attended for medical attention (Cunningham,
2004; Bernstein et al., 2010).
CONCLUSIONS
We must never underestimate the signiﬁcance of a hospital visit as a
motivator for behaviour change. Thus, although we were unable to
establish the effectiveness of EBI, we noted that patients valued the
opportunity to talk about their drinking and identify their personal
risks. Not being allocated to the treatment group seemed to motivate
non-treatment seekers to seek treatment, which was conﬁrmed in a
qualitative analysis of the interview data (unpublished data). Further
research is required but perhaps alternative randomization methods
(Zelen, 1979; Bernstein et al., 2010) to control for bias described
above (McCambridge et al., 2014), and demonstrated in our ﬁnd-
ings should be considered.
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